price hikes

Rising competition, price hikes & declining volumes? Amit Syngle on what Asian Paints will do going ahead

Asian Paints faced a challenging second quarter with muted demand due to uneven rainfall and a slowdown in metro cities. Despite price hikes, competitive intensity remains high. The company is cautiously optimistic about single-digit volume growth in the coming quarter while closely observing AkzoNobel's strategic review of its India business.




price hikes

EpiPen Price Hikes: What to Know

Title: EpiPen Price Hikes: What to Know
Category: Health News
Created: 8/23/2016 12:00:00 AM
Last Editorial Review: 8/23/2016 12:00:00 AM




price hikes

300 percent price hikes push disgruntled VMware customers toward Broadcom rivals

Ars speaks with users and partners unhappy with Broadcom's changes.




price hikes

Trump’s tweets prompt Pfizer to postpone drug price hikes

The president deemed the price rollback a victory, but industry watchers say Pfizer could benefit in the long run




price hikes

Drought slashes soybean production prompting fierce competition for the small crop, warnings of price hikes

Drought has collided with high demand for soybeans, lifting prices by around $500 a tonne, prompting warnings of a price hike for soymilk, tofu and tempeh.




price hikes

CUNY faces calls to freeze price hikes, reimburse tuition amid pandemic

CUNY students, whose median family income is $40,000 a year, say it’s the worst possible time to face additional expenses.




price hikes

How to stop generic drug price hikes (or at least reduce them)

Ravi Gupta, is a resident in internal medicine at Johns Hopkins in Baltimore - and as he said has seen the influence of sudden price hikes on his patients - between 2010 and 2015 more than 300 drugs in the U.S. have seen sudden increases of over %100. Ravi and his co-authors have suggested, and tested the feasibility of, a possible answer to...




price hikes

Trump’s tweets prompt Pfizer to postpone drug price hikes

The president deemed the price rollback a victory, but industry watchers say Pfizer could benefit in the long run